--- sp.seq_info content (copy to Claude) ---
ID   WZY_PSEAE               Reviewed;         438 AA.
AC   G3XCW3; Q51365;
DE   RecName: Full=O-antigen polymerase {ECO:0000303|PubMed:8939432};
DE            Short=O-Ag polymerase {ECO:0000303|PubMed:20824106};
DE            EC=2.4.99.27 {ECO:0000269|PubMed:21498511, ECO:0000269|PubMed:24309320};
DE   AltName: Full=B-band O-antigen polymerase {ECO:0000312|EMBL:AAG06542.1};
GN   Name=wzy {ECO:0000303|PubMed:8939432};
GN   Synonyms=rfc {ECO:0000303|PubMed:7565115};
GN   OrderedLocusNames=PA3154 {ECO:0000312|EMBL:AAG06542.1};
OS   Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM
OS   14847 / LMG 12228 / 1C / PRS 101 / PAO1).
OC   Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria;
OC   Pseudomonadales; Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1] {ECO:0000312|EMBL:AAA85151.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, PATHWAY, AND DISRUPTION
RP   PHENOTYPE.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 /
RC   1C / PRS 101 / PAO1;
RX   PubMed=7565115; DOI=10.1111/j.1365-2958.1995.tb02419.x;
RA   de Kievit T.R., Dasgupta T., Schweizer H., Lam J.S.;
RT   "Molecular cloning and characterization of the rfc gene of Pseudomonas
RT   aeruginosa (serotype O5).";
RL   Mol. Microbiol. 16:565-574(1995).
RN   [2] {ECO:0000312|EMBL:AAC45857.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 /
RC   1C / PRS 101 / PAO1;
RX   PubMed=8939432; DOI=10.1046/j.1365-2958.1996.1351503.x;
RA   Burrows L.L., Charter D.F., Lam J.S.;
RT   "Molecular characterization of the Pseudomonas aeruginosa serotype O5
RT   (PAO1) B-band lipopolysaccharide gene cluster.";
RL   Mol. Microbiol. 22:481-495(1996).
RN   [3] {ECO:0000312|EMBL:AAB07040.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 /
RC   1C / PRS 101 / PAO1;
RA   de Kievet T.R., Lam J.S.;
RL   Submitted (MAR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000312|EMBL:AAG06542.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 /
RC   1C / PRS 101 / PAO1;
RX   PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T., Reizer J.,
RA   Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic
RT   pathogen.";
RL   Nature 406:959-964(2000).
RN   [5]
RP   SUBCELLULAR LOCATION, AND TOPOLOGY.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 /
RC   1C / PRS 101 / PAO1;
RX   PubMed=20824106; DOI=10.1128/mbio.00189-10;
RA   Islam S.T., Taylor V.L., Qi M., Lam J.S.;
RT   "Membrane topology mapping of the O-antigen flippase (Wzx), polymerase
RT   (Wzy), and ligase (WaaL) from Pseudomonas aeruginosa PAO1 reveals novel
RT   domain architectures.";
RL   MBio 1:0-0(2010).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, PATHWAY, AND
RP   MUTAGENESIS OF PHE-165; ASP-168; ARG-175; ARG-176; ARG-180; GLY-186;
RP   SER-193; GLY-196; GLU-275; HIS-276; GLU-277; PHE-279; ARG-290; ARG-291;
RP   GLY-301; ASP-304; SER-308; GLY-311 AND ARG-316.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 /
RC   1C / PRS 101 / PAO1;
RX   PubMed=21498511; DOI=10.1074/jbc.c110.204651;
RA   Islam S.T., Gold A.C., Taylor V.L., Anderson E.M., Ford R.C., Lam J.S.;
RT   "Dual conserved periplasmic loops possess essential charge characteristics
RT   that support a catch-and-release mechanism of O-antigen polymerization by
RT   Wzy in Pseudomonas aeruginosa PAO1.";
RL   J. Biol. Chem. 286:20600-20605(2011).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, PATHWAY, AND
RP   MUTAGENESIS OF ALA-199; ASN-380 AND ARG-385.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 /
RC   1C / PRS 101 / PAO1;
RX   PubMed=24309320; DOI=10.1038/srep03441;
RA   Islam S.T., Huszczynski S.M., Nugent T., Gold A.C., Lam J.S.;
RT   "Conserved-residue mutations in Wzy affect O-antigen polymerization and
RT   Wzz-mediated chain-length regulation in Pseudomonas aeruginosa PAO1.";
RL   Sci. Rep. 3:3441-3441(2013).
CC   -!- FUNCTION: Polymerase involved in the biosynthesis of the B-band
CC       lipopolysaccharide (LPS) (PubMed:21498511, PubMed:24309320,
CC       PubMed:7565115). Catalyzes the polymerization of the O-antigen repeat
CC       units on the periplasmic face of the inner membrane, leading to the
CC       formation of the lipid-linked O-antigen molecule (PubMed:21498511,
CC       PubMed:24309320). {ECO:0000269|PubMed:21498511,
CC       ECO:0000269|PubMed:24309320, ECO:0000269|PubMed:7565115}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=n lipid-linked O-antigen repeat units = a lipid-linked O
CC         antigen + (n-1) polyisoprenyl diphosphate.; EC=2.4.99.27;
CC         Evidence={ECO:0000269|PubMed:21498511, ECO:0000269|PubMed:24309320};
CC   -!- PATHWAY: Bacterial outer membrane biogenesis; LPS O-antigen
CC       biosynthesis. {ECO:0000269|PubMed:21498511,
CC       ECO:0000269|PubMed:24309320, ECO:0000269|PubMed:7565115,
CC       ECO:0000305|PubMed:8939432}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000269|PubMed:20824106,
CC       ECO:0000269|PubMed:21498511, ECO:0000269|PubMed:24309320}; Multi-pass
CC       membrane protein {ECO:0000269|PubMed:20824106}.
CC   -!- DISRUPTION PHENOTYPE: Knockout mutants express B-band LPS containing
CC       complete core plus one 0-repeat unit (PubMed:7565115). Mutants are
CC       still producing A-band LPS (PubMed:7565115).
CC       {ECO:0000269|PubMed:7565115}.
DR   EMBL; U17294; AAA85151.1; -; Genomic_DNA.
DR   EMBL; U50396; AAC45857.1; -; Genomic_DNA.
DR   EMBL; U50599; AAB07040.1; -; Genomic_DNA.
DR   EMBL; AE004091; AAG06542.1; -; Genomic_DNA.
DR   PIR; D83251; D83251.
DR   PIR; S77588; S77588.
DR   RefSeq; NP_251844.1; NC_002516.2.
DR   RefSeq; WP_003124381.1; NZ_QZGE01000023.1.
DR   AlphaFoldDB; G3XCW3; -.
DR   STRING; 208964.PA3154; -.
DR   PaxDb; 208964-PA3154; -.
DR   GeneID; 882652; -.
DR   KEGG; pae:PA3154; -.
DR   PseudoCAP; PA3154; -.
DR   HOGENOM; CLU_051016_0_0_6; -.
DR   InParanoid; G3XCW3; -.
DR   OrthoDB; 7026083at2; -.
DR   BioCyc; PAER208964:G1FZ6-3214-MONOMER; -.
DR   UniPathway; UPA00281; -.
DR   Proteomes; UP000002438; Chromosome.
DR   GO; GO:0009276; C:Gram-negative-bacterium-type cell wall; IDA:PseudoCAP.
DR   GO; GO:0016020; C:membrane; IDA:PseudoCAP.
DR   GO; GO:0098567; C:periplasmic side of plasma membrane; IDA:PseudoCAP.
DR   GO; GO:0005886; C:plasma membrane; IDA:PseudoCAP.
DR   GO; GO:0016757; F:glycosyltransferase activity; ISS:PseudoCAP.
DR   GO; GO:0008755; F:O antigen polymerase activity; IDA:PseudoCAP.
DR   GO; GO:0043165; P:Gram-negative-bacterium-type cell outer membrane assembly; IDA:PseudoCAP.
DR   GO; GO:0009103; P:lipopolysaccharide biosynthetic process; IDA:PseudoCAP.
DR   GO; GO:0009243; P:O antigen biosynthetic process; IDA:PseudoCAP.
PE   1: Evidence at protein level;
KW   Cell inner membrane; Cell membrane; Lipopolysaccharide biosynthesis;
KW   Membrane; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..438
FT                   /note="O-antigen polymerase"
FT                   /id="PRO_0000460971"
FT   TOPO_DOM        1..14
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TRANSMEM        15..31
FT                   /note="Helical"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TOPO_DOM        32..45
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TRANSMEM        46..65
FT                   /note="Helical"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TOPO_DOM        66..73
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TRANSMEM        74..90
FT                   /note="Helical"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TOPO_DOM        91..106
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TRANSMEM        107..123
FT                   /note="Helical"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TOPO_DOM        124..147
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TRANSMEM        148..164
FT                   /note="Helical"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TOPO_DOM        165..200
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TRANSMEM        201..217
FT                   /note="Helical"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TOPO_DOM        218..219
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TRANSMEM        220..236
FT                   /note="Helical"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TOPO_DOM        237..238
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TRANSMEM        239..255
FT                   /note="Helical"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TOPO_DOM        256..257
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TRANSMEM        258..274
FT                   /note="Helical"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TOPO_DOM        275..316
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TRANSMEM        317..335
FT                   /note="Helical"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TOPO_DOM        336..341
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TRANSMEM        342..358
FT                   /note="Helical"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TOPO_DOM        359..360
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TRANSMEM        361..377
FT                   /note="Helical"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TOPO_DOM        378..398
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TRANSMEM        399..418
FT                   /note="Helical"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TOPO_DOM        419..420
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TRANSMEM        421..437
FT                   /note="Helical"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   TOPO_DOM        438
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:20824106"
FT   MUTAGEN         165
FT                   /note="F->A: Does not affect B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         168
FT                   /note="D->A: Does not affect B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         175
FT                   /note="R->A: Forms trace amounts of B-band LPS."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         175
FT                   /note="R->K: Does not affect B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         176
FT                   /note="R->A,K: Abolishes B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         180
FT                   /note="R->A: Forms trace amounts of B-band LPS."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         180
FT                   /note="R->K: Does not affect B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         186
FT                   /note="G->V: Does not affect B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         193
FT                   /note="S->V: Does not affect B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         196
FT                   /note="G->V: Does not affect B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         199
FT                   /note="A->D,E: Decreases B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:24309320"
FT   MUTAGEN         199
FT                   /note="A->K,S: Does not affect B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:24309320"
FT   MUTAGEN         275
FT                   /note="E->A: Does not affect B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         276
FT                   /note="H->A: Does not affect B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         277
FT                   /note="E->A: Does not affect B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         279
FT                   /note="F->A: Does not affect B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         290
FT                   /note="R->A,K: Abolishes B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         291
FT                   /note="R->A,K: Abolishes B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         301
FT                   /note="G->V: Abolishes B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         304
FT                   /note="D->A: Does not affect B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         308
FT                   /note="S->V: Does not affect B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         311
FT                   /note="G->V: Does not affect B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         316
FT                   /note="R->A: Does not affect B-band LPS biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:21498511"
FT   MUTAGEN         380
FT                   /note="N->A: Decreases B-band LPS biosynthesis.
FT                   Destabilizes the C-terminus of the protein."
FT                   /evidence="ECO:0000269|PubMed:24309320"
FT   MUTAGEN         385
FT                   /note="R->A: Decreases B-band LPS biosynthesis.
FT                   Destabilizes the C-terminus of the protein."
FT                   /evidence="ECO:0000269|PubMed:24309320"
FT   CONFLICT        406
FT                   /note="S -> P (in Ref. 1; AAA85151, 2; AAC45857 and 3;
FT                   AAB07040)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        419
FT                   /note="M -> I (in Ref. 1; AAA85151, 2; AAC45857 and 3;
FT                   AAB07040)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   438 AA;  48919 MW;  35E31DC437B9295D CRC64;
//

--- End of sp.seq_info ---

--- species summary (copy to Claude) ---
Number  Rank    Taxon
3	6	Microbacterium.
3	5	Phyllobacteriaceae
3	5	Micromonosporaceae
3	5	Microbacteriaceae
6	4	Micrococcales
4	4	Hyphomicrobiales
3	4	Micromonosporales
9	3	Actinomycetes
4	3	Alphaproteobacteria
3	3	Gammaproteobacteria
3	3	Betaproteobacteria
9	2	Actinomycetota
4	2	Bacteroidota
3	2	Bacillota
10	2	Pseudomonadota
16	1	Pseudomonadati
13	1	Bacillati
29	0	Bacteria
Total of 29 proteins found

--- End of species summary ---

--- Domain architectures (copy to Claude) ---
A0A099PEB9	O-ANTIGEN POLYMERASE {ECO    195.9    5.4e-54   1   1.0  38.1
	G3XCW3                    	     2	   425	   195.6

A0A099WG51	B-BAND O-ANTIGEN POLYMERA     36.5    1.3e-05   1   1.2  28.4
	G3XCW3                    	    20	   423	    36.5

A0A0A1YK74	UNCHARACTERIZED PROTEIN {     64.8    3.3e-14   1   1.1  31.1
	G3XCW3                    	     2	   408	    64.4

A0A0F4PUH8	OLIGOSACCHARIDE REPEAT UN     49.6    1.3e-09   1   2.0  30.4
	G3XCW3                    	     7	   418	    47.4

A0A0M1JDH7	OLIGOSACCHARIDE REPEAT UN     35.0    3.6e-05   1   1.0  10.8
	G3XCW3                    	     1	   186	    34.9

A0A0Q5LLJ2	UNCHARACTERIZED PROTEIN {     37.5    6.4e-06   1   1.2   3.7
	G3XCW3                    	   176	   436	    36.9

A0A0Q8R0C2	OLIGOSACCHARIDE REPEAT UN     44.4    5.1e-08   1   1.1  26.7
	G3XCW3                    	     5	   423	    44.0

A0A1C6SMI1	OLIGOSACCHARIDE REPEAT UN     70.6    5.9e-16   1   1.0  23.8
	G3XCW3                    	    37	   455	    70.2

A0A1G5SDI2	O-ANTIGEN POLYMERASE {ECO     51.6    3.3e-10   1   1.0  42.4
	G3XCW3                    	     4	   430	    51.2

A0A1M6PWL3	OLIGOSACCHARIDE REPEAT UN     28.5     0.0035   1   1.1  37.7
	G3XCW3                    	     3	   420	    28.0

A0A1V8RLV3	UNCHARACTERIZED PROTEIN {     30.9    0.00065   1   1.1  30.8
	G3XCW3                    	     9	   440	    30.5

A0A269PQ51	OLIGOSACCHARIDE REPEAT UN     27.7     0.0062   1   1.1  35.3
	G3XCW3                    	     4	   421	    27.2

A0A2V1JYI7	OLIGOSACCHARIDE REPEAT UN     73.6    7.1e-17   1   1.1  40.6
	G3XCW3                    	     9	   429	    73.2

A0A2W2CU95	OLIGOSACCHARIDE REPEAT UN     57.2    6.9e-12   1   1.0  26.1
	G3XCW3                    	    33	   457	    56.8

A0A3N4AC84	OLIGOSACCHARIDE REPEAT UN     37.7    5.4e-06   1   1.7  37.9
	G3XCW3                    	    89	   418	    37.7

A0A432V2J6	OLIGOSACCHARIDE REPEAT UN     32.0    0.00029   1   1.0  21.2
	G3XCW3                    	     1	   297	    31.8

A0A432V9N0	OLIGOSACCHARIDE REPEAT UN     41.1    5.3e-07   1   1.1  27.9
	G3XCW3                    	    10	   417	    40.8

A0A479ZXJ7	O-ANTIGEN POLYMERASE {ECO     31.1    0.00056   1   1.2  32.1
	G3XCW3                    	     5	   436	    30.4

A0A4P9JA59	OLIGOSACCHARIDE REPEAT UN     28.7     0.0031   1   1.2  22.8
	G3XCW3                    	    20	   437	    28.2

A0A4Q0XQC4	OLIGOSACCHARIDE REPEAT UN     44.0    6.6e-08   1   2.0  32.2
	G3XCW3                    	   113	   417	    44.0

A0A4Q5RST1	O-ANTIGEN LIGASE DOMAIN-C     38.8    2.6e-06   1   1.5  21.1
	G3XCW3                    	    76	   452	    37.7

A0A4S4C1I9	OLIGOSACCHARIDE REPEAT UN     27.5     0.0071   1   1.9  32.5
	G3XCW3                    	    84	   410	    27.5

A0A518E4L9	O-ANTIGEN LIGASE {ECO:000     47.0    8.2e-09   1   1.0  31.0
	G3XCW3                    	     3	   432	    46.7

A0A542XE36	OLIGOSACCHARIDE REPEAT UN     32.5    0.00022   1   1.4  19.9
	G3XCW3                    	    10	   433	    31.6

A0A563E072	O-ANTIGEN LIGASE FAMILY P     35.9      2e-05   1   1.0  24.2
	G3XCW3                    	     2	   429	    35.5

A0A5S3PVI4	OLIGOSACCHARIDE REPEAT UN     29.6     0.0016   1   1.2  38.2
	G3XCW3                    	     4	   424	    28.9

A0A7W6J3Q8	UNCHARACTERIZED PROTEIN {     43.3    1.1e-07   1   1.1  28.9
	G3XCW3                    	     5	   422	    42.9

A0A849HHM9	OLIGOSACCHARIDE REPEAT UN     63.3    9.3e-14   1   1.0  23.4
	G3XCW3                    	    16	   420	    62.9

A0A917MEV2	OLIGOSACCHARIDE REPEAT UN     29.7     0.0015   1   1.8  39.1
	G3XCW3                    	    98	   422	    29.7

A0A931CAC2	UNCHARACTERIZED PROTEIN {     39.3    1.8e-06   1   1.0  23.4
	G3XCW3                    	    13	   437	    39.0

A0A939TXK9	OLIGOSACCHARIDE REPEAT UN     45.5    2.5e-08   1   1.0  27.7
	G3XCW3                    	    12	   441	    45.0

A0A9W6HRG8	UNCHARACTERIZED PROTEIN {     40.5    8.1e-07   1   1.1  18.5
	G3XCW3                    	    14	   437	    40.1

A0A9W6HSE9	OLIGOSACCHARIDE REPEAT UN     47.5    5.7e-09   1   1.0  22.0
	G3XCW3                    	    11	   442	    47.2

A1VRZ1	O-ANTIGEN POLYMERASE {ECO:000     50.8    5.9e-10   1   1.3  37.5
	G3XCW3                    	    29	   423	    50.2

G3XCW3	O-ANTIGEN POLYMERASE {ECO:000030   1004.8   1.9e-299   1   1.0  40.7
	G3XCW3                    	     1	   438	  1004.7

I8X760	O-ANTIGEN POLYMERASE {ECO:000     33.4    0.00011   1   1.0  41.4
	G3XCW3                    	    10	   434	    33.1

K9S9G9	O-ANTIGEN POLYMERASE {ECO:000     36.0    1.9e-05   1   1.1  31.1
	G3XCW3                    	    12	   447	    35.5

L0G5L5	OLIGOSACCHARIDE REPEAT UNIT P     28.6     0.0033   1   1.5  36.1
	G3XCW3                    	     9	   426	    27.6

W9T9C1	B-BAND O-ANTIGEN POLYMERASE {     71.1    4.2e-16   1   1.6  33.7
	G3XCW3                    	     3	   423	    69.6


--- End of Domain architectures ---

--- PaperBLAST literature results (copy to Claude) ---
================================================================================
Protein: G3XCW3 (E-value: 1.7e-301, Score: 1004.8)
Mentioned as: G3XCW3
Description: O-antigen polymerase
Organism: Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)
  SwissProt:  - O-antigen polymerase; O-Ag polymerase; B-band O-antigen polymerase; EC 2.4.99.27
PMID: 40066032
Source: EuropePMC
Title: Proteome-wide identification of druggable targets and inhibitors for multidrug-resistant &lt;i&gt;Pseudomonas aeruginosa&lt;/i&gt; using an integrative subtractive proteomics and virtual screening approach
Journal: Heliyon (2025)
Snippet: 3613 Q9HZI2 4695 Q9I5A9 368 G3XCV7 1450 Q9HVZ4 2532 Q9HU31 3614 Q9HZI4 4696 Q9I5B0 369 G3XCW3 1451 Q9HVZ5 2533 Q9HU33 3615 Q9HZI5 4697 Q9I5B1 370 G3XCW9 1452 Q9HVZ6 2534 Q9HU34 3616 Q9HZI6 4698 Q9I5B2 371 G3XCX1 1453 Q9HW07 2535 Q9HU35 3617 Q9HZI8 4699 Q9I5B3 372 G3XCZ0

================================================================================
Protein: G3XCW3 (E-value: 1.7e-301, Score: 1004.8)
Mentioned as: WZY_PSEAE
Description: O-antigen polymerase
Organism: Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)
  SwissProt:  - O-antigen polymerase; O-Ag polymerase; B-band O-antigen polymerase; EC 2.4.99.27
PMID: 7565115
Source: SwissProt
Snippet: FUNCTION: Polymerase involved in the biosynthesis of the B-band lipopolysaccharide (LPS) (PubMed:21498511, PubMed:24309320, PubMed:7565115). Catalyzes the polymerization of the O-antigen repeat units on the periplasmic face of the inner membrane, leading to the formation of the lipid-linked O-antigen molecule (PubMed:21498511, PubMed:24309320). {ECO:0000269|PubMed:21498511, ECO:0000269|PubMed:24309320, ECO:0000269|PubMed:7565115}._:::_CATALYTIC ACTIVITY: Reaction=n lipid-linked O-antigen repeat ...

================================================================================
Protein: G3XCW3 (E-value: 1.7e-301, Score: 1004.8)
Mentioned as: WZY_PSEAE
Description: O-antigen polymerase
Organism: Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)
  SwissProt:  - O-antigen polymerase; O-Ag polymerase; B-band O-antigen polymerase; EC 2.4.99.27
PMID: 20824106
Source: SwissProt
Snippet: FUNCTION: Polymerase involved in the biosynthesis of the B-band lipopolysaccharide (LPS) (PubMed:21498511, PubMed:24309320, PubMed:7565115). Catalyzes the polymerization of the O-antigen repeat units on the periplasmic face of the inner membrane, leading to the formation of the lipid-linked O-antigen molecule (PubMed:21498511, PubMed:24309320). {ECO:0000269|PubMed:21498511, ECO:0000269|PubMed:24309320, ECO:0000269|PubMed:7565115}._:::_CATALYTIC ACTIVITY: Reaction=n lipid-linked O-antigen repeat ...


--- End of PaperBLAST literature results ---

--- TED domain information (copy to Claude) ---
Protein_Accession	TED_Domains	Domain_Count	Domain_IDs	Domain_Ranges	Overlap_with_Pfam

--- End of TED domain information ---

--- Current DESC file (copy to Claude) ---
ID   ShortName
DE   Family description
AU   Bateman A;0000-0002-6982-4660
SE   ECOD:G3XCW3
GA   27.00 27.00;
TC   27.50 27.20;
NC   25.80 25.80;
BM   hmmbuild  -o /dev/null HMM SEED
SM   hmmsearch -Z 90746521 --cpu 8 -E 1000 HMM pfamseq
TP   Family

--- End of Current DESC file ---